METASPRAY Nasal Spray
2016-1-27 · Mometasone furoate monohydrate administered as a nasal spray suspension has very low bioavailability (<1%) in plasma using a sensitive assay with a lower quantitation limit (LOQ) of 0.25 pcg/mL. Distribution. The in vitro protein binding for mometasone furoate monohydrate was reported to be 98–99% in the concentration range of 5–500 ng/mL.
Get Price